Lexaria Bioscience Corp Stock Technical Analysis
| LEXX Stock | USD 0.77 0.02 3.06% |
As of the 3rd of February, Lexaria Bioscience secures the Downside Deviation of 9.81, mean deviation of 4.85, and Risk Adjusted Performance of 0.0093. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lexaria Bioscience Corp, as well as the relationship between them.
Lexaria Bioscience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lexaria, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LexariaLexaria Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Lexaria Bioscience Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 4.5 | Buy | 2 | Odds |
Most Lexaria analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Lexaria stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Lexaria Bioscience Corp, talking to its executives and customers, or listening to Lexaria conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexaria Bioscience. Expected growth trajectory for Lexaria significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Lexaria Bioscience assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 1.071 | Return On Assets | Return On Equity |
The market value of Lexaria Bioscience Corp is measured differently than its book value, which is the value of Lexaria that is recorded on the company's balance sheet. Investors also form their own opinion of Lexaria Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Lexaria Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexaria Bioscience's market value can be influenced by many factors that don't directly affect Lexaria Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Lexaria Bioscience's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lexaria Bioscience represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Lexaria Bioscience's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Lexaria Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lexaria Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lexaria Bioscience.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Lexaria Bioscience on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Lexaria Bioscience Corp or generate 0.0% return on investment in Lexaria Bioscience over 90 days. Lexaria Bioscience is related to or competes with Hoth Therapeutics, Allarity Therapeutics, Lixte Biotechnology, Entero Therapeutics, Cingulate, Briacell Therapeutics, and CASI Pharmaceuticals. Lexaria Bioscience Corp. operates as a biotechnology company More
Lexaria Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lexaria Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lexaria Bioscience Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.81 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 42.53 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 8.94 |
Lexaria Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lexaria Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lexaria Bioscience's standard deviation. In reality, there are many statistical measures that can use Lexaria Bioscience historical prices to predict the future Lexaria Bioscience's volatility.| Risk Adjusted Performance | 0.0093 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.01) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexaria Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lexaria Bioscience February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0093 | |||
| Market Risk Adjusted Performance | 0.0042 | |||
| Mean Deviation | 4.85 | |||
| Semi Deviation | 8.74 | |||
| Downside Deviation | 9.81 | |||
| Coefficient Of Variation | 206553.21 | |||
| Standard Deviation | 7.19 | |||
| Variance | 51.69 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 42.53 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 8.94 | |||
| Downside Variance | 96.29 | |||
| Semi Variance | 76.37 | |||
| Expected Short fall | (4.45) | |||
| Skewness | (1.72) | |||
| Kurtosis | 7.12 |
Lexaria Bioscience Corp Backtested Returns
Lexaria Bioscience Corp has Sharpe Ratio of -0.0344, which conveys that the firm had a -0.0344 % return per unit of risk over the last 3 months. Lexaria Bioscience exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lexaria Bioscience's Risk Adjusted Performance of 0.0093, downside deviation of 9.81, and Mean Deviation of 4.85 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.12, which conveys a somewhat significant risk relative to the market. Lexaria Bioscience returns are very sensitive to returns on the market. As the market goes up or down, Lexaria Bioscience is expected to follow. At this point, Lexaria Bioscience Corp has a negative expected return of -0.25%. Please make sure to verify Lexaria Bioscience's treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to decide if Lexaria Bioscience Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.04 |
Very weak reverse predictability
Lexaria Bioscience Corp has very weak reverse predictability. Overlapping area represents the amount of predictability between Lexaria Bioscience time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lexaria Bioscience Corp price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Lexaria Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Lexaria Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Lexaria Bioscience Corp Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Lexaria Bioscience Corp across different markets.
About Lexaria Bioscience Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lexaria Bioscience Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lexaria Bioscience Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lexaria Bioscience Corp price pattern first instead of the macroeconomic environment surrounding Lexaria Bioscience Corp. By analyzing Lexaria Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lexaria Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lexaria Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 121.44 | 190.46 | 26.35 | 25.03 | PTB Ratio | 6.03 | 5.3 | 54.87 | 57.61 |
Lexaria Bioscience February 3, 2026 Technical Indicators
Most technical analysis of Lexaria help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lexaria from various momentum indicators to cycle indicators. When you analyze Lexaria charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0093 | |||
| Market Risk Adjusted Performance | 0.0042 | |||
| Mean Deviation | 4.85 | |||
| Semi Deviation | 8.74 | |||
| Downside Deviation | 9.81 | |||
| Coefficient Of Variation | 206553.21 | |||
| Standard Deviation | 7.19 | |||
| Variance | 51.69 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.01) | |||
| Maximum Drawdown | 42.53 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 8.94 | |||
| Downside Variance | 96.29 | |||
| Semi Variance | 76.37 | |||
| Expected Short fall | (4.45) | |||
| Skewness | (1.72) | |||
| Kurtosis | 7.12 |
Lexaria Bioscience February 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Lexaria stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 8,841 | ||
| Daily Balance Of Power | (0.40) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 0.76 | ||
| Day Typical Price | 0.76 | ||
| Price Action Indicator | (0.01) |
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.